CC
VOR icon

Clearline Capital’s Vor Biopharma VOR Stock Holding History

Clearline Capital’s Portfolio VOR Stock Details VOR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.25M Sell
285,276
-40,892
-13% -$619K 0.31% 64
2026
Q1 		$5.82M Buy
+326,168
New +$4.6M 0.3% 64

Other funds holding VOR

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return

Clearline Capital's VOR Position: Q2 2026 in Review

Clearline Capital reduced its Vor Biopharma (VOR) stake by 13% in Q2 2026, selling an estimated $619K and leaving 285,276 shares worth $5.25M. The position accounts for 0.31% of the portfolio, ranked #64.

Clearline Capital first reported a position in VOR in Q1 2026 and has held it in 2 quarters since. The position peaked at $5.82M in Q1 2026. 102 funds tracked by Wall St. Rank hold VOR as of Q2 2026.

  • Clearline Capital held 285,276 shares of Vor Biopharma worth $5.25M as of Q2 2026.
  • Clearline Capital sold 40,892 Vor Biopharma shares in Q2 2026, an estimated $619K.
  • Vor Biopharma made up 0.31% of Clearline Capital's portfolio in Q2 2026, its #64 holding.
  • Clearline Capital first reported a position in Vor Biopharma in Q1 2026 and has held it in 2 quarters since.
  • Clearline Capital's Vor Biopharma position peaked at $5.82M in Q1 2026.
  • 102 funds tracked by Wall St. Rank held Vor Biopharma as of Q2 2026.

Based on Clearline Capital's 13F filing for Q2 2026, filed 14 Aug 2026.